In a mouse model of melanoma, NLRP3-/- mice that were vaccinated with DC-based vaccines had significantly increased survival compared to wild-type controls, possibly due to the presence of fewer MDSCs in NLRP3-/- mice, which may have contributed to impaired tumorigenesis (47). The gene discussed is NLRP3; the disease is melanoma.